The EphB4 receptor promotes the growth of melanoma cells expressing the ephrin-B2 ligand

Pigment Cell and Melanoma Research

Volumn 23, Issue 5, 2010, Pages 684-687

  Yang, Nai Ying ^a,b   Lopez Bergami, Pablo ^b,e   Goydos, James S ^c   Yip, Dana ^c   Walker, Ameae M ^b   Pasquale, Elena B ^b,d   Ethell, Iryna M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BURNHAM INSTITUTE   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; EPHRIN B2; EPHRIN RECEPTOR B4; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BCL 2; PROTEIN KINASE B;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CANCER GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; LETTER; MELANOMA; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION;

ANIMALS; CELL PROLIFERATION; EPHRIN-B2; LIGANDS; MELANOMA; MICE; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR, EPHB4; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77956326885     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2010.00745.x     Document Type: Letter

References (12)

1. Gray-Schopfer, V., Wellbrock, C. Marais, R. (2007). Melanoma biology and new targeted therapy. Nature 445, 851 857.
2. Hess, A.R., Margaryan, N.V., Seftor, E.A. Hendrix, M.J. (2007). Deciphering the signaling events that promote melanoma tumor cell vasculogenic mimicry and their link to embryonic vasculogenesis: role of the Eph receptors. Dev. Dyn. 236, 3283 3296.
3. Huang, X., Yamada, Y., Kidoya, H., Naito, H., Nagahama, Y., Kong, L., Katoh, S.Y., Li, W.L., Ueno, M. Takakura, N. (2007). EphB4 overexpression in B16 melanoma cells affects arterial-venous patterning in tumor angiogenesis. Cancer Res. 67, 9800 9808.
4. Kerbel, R. Folkman, J. (2002). Clinical translation of angiogenesis inhibitors. Nat. Rev. Cancer 2, 727 739.
5. Kumar, S.R., Singh, J., Xia, G. et al. (2006). Receptor tyrosine kinase EphB4 is a survival factor in breast cancer. Am. J. Pathol. 169, 279 293.
6. Lopez-Bergami, P., Fitchman, B. Ronai, Z. (2008). Understanding signaling cascades in melanoma. Photochem. Photobiol. 84, 289 306.
7. Margaryan, N.V., Strizzi, L., Abbott, D.E., Seftor, E.A., Rao, M.S., Hendrix, M.J. Hess, A.R. (2009). EphA2 as a promoter of melanoma tumorigenicity. Cancer Biol. Ther. 8, 279 288.
8. Meyer, S., Hafner, C., Guba, M., Flegel, S., Geissler, E.K., Becker, B., Koehl, G.E., Orso, E., Landthaler, M. Vogt, T. (2005). Ephrin-B2 overexpression enhances integrin-mediated ECM-attachment and migration of B16 melanoma cells. Int. J. Oncol. 27, 1197 1206.
9. Pasquale, E.B. (2010). Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat. Rev. Cancer 10, 165 180.
10. Smalley, K.S., Sondak, V.K. Weber, J.S. (2009). c-KIT signaling as the driving oncogenic event in sub-groups of melanomas. Histol. Histopathol. 24, 643 650.
11. Steinle, J.J., Meininger, C.J., Forough, R., Wu, G., Wu, M.H. Granger, H.J. (2002). Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway. J. Biol. Chem. 277, 43830 43835.
12. Yang, N.Y., Pasquale, E.B., Owen, L.B. Ethell, I.M. (2006). The EphB4 receptor-tyrosine kinase promotes the migration of melanoma cells through rho-mediated actin cytoskeleton reorganization. J. Biol. Chem. 281, 32574 32586.